Moolec Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Moolec Science SA
MLEC Stock   4.47  0.48  12.03%   
Moolec Science's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Moolec Science's valuation are provided below:
Gross Profit
-639.5 K
Market Capitalization
3.2 M
Enterprise Value Revenue
0.7227
Revenue
7.8 M
Earnings Share
(258.69)
We have found one hundred twenty available fundamental ratios for Moolec Science, which can be analyzed and compared to other ratios and to its peers in the industry. Investors should ensure to check all of Moolec Science's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

Moolec Science Total Revenue

402.84 Million

Check Moolec Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moolec Science's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.9 M, Other Operating Expenses of 415.5 M or Total Operating Expenses of 150.3 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.0 or Days Sales Outstanding of 23.81. Moolec financial statements analysis is a perfect complement when working with Moolec Science Valuation or Volatility modules.
  
Build AI portfolio with Moolec Stock
Check out the analysis of Moolec Science Correlation against competitors.

Moolec Science Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets247.2 M235.4 M133.9 M
Pretty Stable
Short and Long Term Debt Total298.1 M283.9 M49.9 M
Slightly volatile
Other Current Liabilities4.2 M2.6 M1.9 M
Slightly volatile
Total Current Liabilities285 M271.5 M48.6 M
Slightly volatile
Property Plant And Equipment Net4.2 M4 M852.8 K
Slightly volatile
Accounts Payable7.8 M7.5 M1.9 M
Slightly volatile
Cash839 K883.1 K894.3 K
Slightly volatile
Non Current Assets Total209.5 M199.5 M126.2 M
Very volatile
Cash And Short Term Investments10.9 M10.4 M2.5 M
Slightly volatile
Common Stock Shares Outstanding368.4 K387.8 K11.7 M
Slightly volatile
Liabilities And Stockholders Equity247.2 M235.4 M133.9 M
Pretty Stable
Non Current Liabilities Total62.2 M59.3 M13.9 M
Slightly volatile
Other Current Assets12.9 K13.6 K215.5 K
Slightly volatile
Other Stockholder Equity42.6 M45.2 M20 M
Slightly volatile
Total Liabilities347.3 M330.7 M62.4 M
Slightly volatile
Net Invested Capital218.3 M207.9 M41.2 M
Slightly volatile
Property Plant And Equipment Gross4.2 M4 M866.7 K
Slightly volatile
Total Current Assets37.7 M35.9 M7.7 M
Slightly volatile
Capital Stock688 K1.3 M673.6 K
Slightly volatile
Short Term Debt274.4 M261.4 M45.3 M
Slightly volatile
Intangible Assets90.9 M86.5 M19.1 M
Slightly volatile
Common Stock931.2 K980.3 K83.8 M
Slightly volatile
Property Plant Equipment7.8 K8 K9.9 K
Slightly volatile
Long Term Debt11.5 M22.5 M3.9 M
Slightly volatile
Short and Long Term Debt274.3 M261.2 M47 M
Slightly volatile
Accumulated Other Comprehensive Income4.8 M4.5 M798.2 K
Slightly volatile
Non Current Liabilities Other204.5 K226 K182.5 K
Slightly volatile
Long Term Investments102.9 M108.3 M94.5 M
Slightly volatile

Moolec Science Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization26.9 M25.6 M4.6 M
Slightly volatile
Other Operating Expenses415.5 M395.7 M69.5 M
Slightly volatile
Total Operating Expenses150.3 M143.2 M25.8 M
Slightly volatile
Interest Expense50.5 M48.1 M8.3 M
Slightly volatile
Selling General Administrative107.3 M102.2 M22.5 M
Slightly volatile
Selling And Marketing Expenses776.5 K739.5 K254.1 K
Slightly volatile
Research Development11.2 M10.6 M2.7 M
Slightly volatile
Reconciled Depreciation26.9 M25.6 M4.5 M
Slightly volatile

Moolec Science Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings21.5 M20.5 M5.6 M
Slightly volatile
Begin Period Cash Flow64 M60.9 M10.7 M
Slightly volatile
Depreciation26.9 M25.6 M4.5 M
Slightly volatile
Total Cash From Financing Activities11.2 M11.8 M11.7 M
Slightly volatile
End Period Cash Flow839 K883.1 K679.8 K
Slightly volatile
Change To Netincome1.4 M2 M1.1 M
Slightly volatile
Change To Liabilities542.1 K1.1 M350.7 K
Slightly volatile
Stock Based Compensation3.8 M3.9 M4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.02.1116.1 K
Slightly volatile
Days Sales Outstanding23.8125.07531
Slightly volatile
Average Payables1.5 M1.4 M515.7 K
Slightly volatile
Stock Based Compensation To Revenue0.40.4237.0993
Slightly volatile
Capex To Depreciation0.280.291.1806
Slightly volatile
EV To Sales2.812.9516.1 K
Slightly volatile
Inventory Turnover92.8388.4118.209
Slightly volatile
Days Of Inventory On Hand4.064.27151
Pretty Stable
Payables Turnover31.9730.456.3517
Slightly volatile
Sales General And Administrative To Revenue1.271.3440.3535
Slightly volatile
Average Inventory3.1 M3.8 M3.4 M
Slightly volatile
Research And Ddevelopement To Revenue0.03020.03181.1641
Slightly volatile
Capex To Revenue0.01850.01950.1563
Slightly volatile
Cash Per Share1.321.260.2612
Slightly volatile
Days Payables Outstanding11.7912.41628
Slightly volatile
Income Quality0.190.20.5566
Slightly volatile
Intangibles To Total Assets0.50.420.6832
Slightly volatile
Current Ratio0.110.120.5977
Slightly volatile
Receivables Turnover15.8215.073.4346
Slightly volatile
Capex Per Share0.830.790.1509
Slightly volatile
Average Receivables1.3 M1.4 M1.6 M
Slightly volatile
Revenue Per Share48.7846.468.6674
Slightly volatile
Interest Debt Per Share42.2140.27.5091
Slightly volatile
Debt To Assets1.141.090.2353
Slightly volatile
Operating Cycle27.8729.34682
Slightly volatile
Days Of Payables Outstanding11.7912.41628
Slightly volatile
Ebt Per Ebit15.3314.63.8795
Slightly volatile
Total Debt To Capitalization1.291.230.2857
Slightly volatile
Quick Ratio0.130.140.552
Slightly volatile
Net Income Per E B T0.720.7534.299
Slightly volatile
Cash Ratio0.00360.00370.3204
Slightly volatile
Cash Conversion Cycle16.0916.9353.8172
Pretty Stable
Days Of Inventory Outstanding4.064.27151
Pretty Stable
Days Of Sales Outstanding23.8125.07531
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.871.111.0317
Pretty Stable
Fixed Asset Turnover91.4887.1316.9896
Slightly volatile
Debt Ratio1.141.090.2353
Slightly volatile
Price Sales Ratio2.02.1116.1 K
Slightly volatile
Asset Turnover1.541.470.3112
Slightly volatile

Moolec Science Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.8 B5.8 B5.7 B
Pretty Stable
Enterprise Value4.8 B5.8 B5.7 B
Pretty Stable

Moolec Fundamental Market Drivers

Moolec Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Moolec Science Financial Statements

Moolec Science stakeholders use historical fundamental indicators, such as Moolec Science's revenue or net income, to determine how well the company is positioned to perform in the future. Although Moolec Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in Moolec Science's assets and liabilities are reflected in the revenues and expenses on Moolec Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Moolec Science SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 K1.4 K
Total Revenue383.7 M402.8 M
Cost Of Revenue252.5 M265.2 M
Stock Based Compensation To Revenue 0.42  0.40 
Sales General And Administrative To Revenue 1.34  1.27 
Research And Ddevelopement To Revenue 0.03  0.03 
Capex To Revenue 0.02  0.02 
Revenue Per Share 46.46  48.78 
Ebit Per Revenue(0.03)(0.03)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
When determining whether Moolec Science SA is a strong investment it is important to analyze Moolec Science's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Moolec Science's future performance. For an informed investment choice regarding Moolec Stock, refer to the following important reports:
How To Invest In Moolec
Details
Is Moolec Stock a good investment?
Details
What is Moolec Science's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Moolec Science Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moolec Science. If investors know Moolec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moolec Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(258.69)
Revenue Per Share
2.041
Quarterly Revenue Growth
9.483
Return On Assets
(0.22)
Return On Equity
(1.75)
The market value of Moolec Science SA is measured differently than its book value, which is the value of Moolec that is recorded on the company's balance sheet. Investors also form their own opinion of Moolec Science's value that differs from its market value or its book value, called intrinsic value, which is Moolec Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moolec Science's market value can be influenced by many factors that don't directly affect Moolec Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Moolec Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moolec Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moolec Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY